Crosslinking of gum-based composite scaffolds for enhanced strength and stability: A comparative study between sodium trimetaphosphate and glutaraldehyde.

Tissue engineering is one of the potential fields in the domain of regenerative medicine. Engineered scaffolds are an excellent substitute for the conventional use of bone grafts as they are biocompatible, economic, and provide limitless supply with no risk of disease transmission. Gum-based scaffolds present a good scope for studying tissue-engineering models and analyzing controlled drug delivery. Uniform blending of the gums and the presence of the optimal concentration of appropriate crosslinkers are very crucial for biodegradability nature. Gum-based scaffolds containing gellan gum, xanthan gum, polyvinyl alcohol, and hydroxyapatite, cross-linked with either glutaraldehyde (GA) or sodium trimetaphosphate (STMP) were fabricated to study the efficiency of crosslinkers and were characterized for degradation profile, swelling capacity, porosity, mechanical strength, morphology, X-ray diffraction, Fourier-transform infrared, and in vitro biocompatibility. Scaffolds crosslinked with STMP exhibited higher degradation rate at Day 21 than scaffolds crosslinked with GA. However, higher compressive strength was obtained for scaffolds cross-linked with STMP signifying that they have a better ability to resist compressive forces. Superior cell viability was observed in STMP-crosslinked scaffolds. In conclusion, STMP serves as a better crosslinker in comparison to GA and can be used in the fabrication of scaffolds for bone tissue engineering.

Gum based 3D composite scaffolds for bone tissue engineering applications.

The increase in population, greater life expectancy, and lifestyle choices have caused a drastic increase in the number of bone diseases such as bone tumours, osteoarthritis and bone fractures. This results in the dire need for treatment options such as suitable bone grafts that can be easily fabricated, and are economical. In this study, fabricated composite scaffolds are made from polysaccharide biopolymers, namely gellan and guar gum, and hydroxyapatite by freeze drying method. The developed scaffolds of optimum concentration showed a maximum percentage degradation of 13.7% only until 21 days in phosphate buffered saline solution, and minimum swelling capacity. The mechanically stable scaffolds (compressive strength equivalent to cancellous bone region, ˜3-30 MPa) amongst them were then subjected to characterization tests-scanning electron microscopy, fourier transform infrared spectroscopy, X-ray diffraction, swelling ratio percentage determination, degradation profile study and water vapour transmission study. The cytotoxic evaluation of the optimised scaffolds was performed using MTT assay with murine fibroblast (L929) cells and osteosarcoma (MG63) cells. It was found that the scaffolds were non-cytotoxic and additionally, the cells had proliferated well within the scaffolds, which was confirmed by MTT assay at 1, 4 and 7 days after cell seeding onto the scaffolds.

A brachytherapy plan evaluation tool for interstitial applications.

Radiobiological metrics such as tumor control probability (TCP) and normal tissue complication probability (NTCP) help in assessing the quality of brachytherapy plans. Application of such metrics in clinics as well as research is still inadequate. This study presents the implementation of two indigenously designed plan evaluation modules: Brachy_TCP and Brachy_NTCP. Evaluation tools were constructed to compute TCP and NTCP from dose volume histograms (DVHs) of any interstitial brachytherapy treatment plan. The computation module was employed to estimate probabilities of tumor control and normal tissue complications in ten cervical cancer patients based on biologically effective equivalent uniform dose (BEEUD). The tumor control and normal tissue morbidity were assessed with clinical followup and were scored. The acute toxicity was graded using common terminology criteria for adverse events (CTCAE) version 4.0. Outcome score was found to be correlated with the TCP/NTCP estimates. Thus, the predictive ability of the estimates was quantified with the clinical outcomes. Biologically effective equivalent uniform dose-based formalism was found to be effective in predicting the complexities and disease control.

SU-E-T-130: IMAT Patient Specific Quality Assurance Using ArcCHECK Diode Array Detector.

PURPOSE: To evaluate the IMAT patient specific quality assurance (QA) performed using ArcCHECK detector array in reference with standard ion chamber for routine clinical use. METHODS: Twelve patient plans having different tumor sites chosen for this study. On Eclipse planning system,IMAT patient plans were calculated on ArcCHECK phantom inserted with Ion chamber using superposition algorithm. ArcCHECK is a cylindrical phantom with a three-dimensional array of 1386 diode detectors, arranged in a spiral pattern, with 10 mm diode spacing. These plans delivered from Clinac-iX linac equipped with 120 MLC. Point dose and Dose/fluence map were measured simultaneously with ion chamber (IC-15) and ArcCHECK diode array detector respectively. Point doses, dose/fluences map and dose at central axis (CAX) on ArcCHECK phantom were compared with their respective TPS calculated values. RESULTS: The ion chamber measurements are in good agreement with TPS calculated doses. Mean difference between them is 0.50% with standard deviation is 0.51%. Concordance correlation coefficient (CCC) obtained for ion chamber base absolute dose measurements is 0.9996. These results demonstrate a strong correlation between the absolute dose predicted by our TPS and the measured dose. The precision of the TPS software was 0.9999, and its accuracy was 0.9997.The agreement between ArcCHECK doses and TPS predictions on the CAX, shown CCC of 0.9978 (the mean difference in the central axis dose is 2.11%). The 95% Confidence Interval is from 0.9932 to 0.9995. In gamma analysis of dose/fluence map the mean passing rate was 98.53% for 3% dose difference and 3mm distance to agreement. CONCLUSIONS: The IMAT patient specific QA with Ion chamber and ArcCHECK phantom are consistent with the TPS calculated dose. Statistically good agreement observed between ArcCHECK measured and TPS calculated. Hence it can be used for routine IMAT QA.

SU-E-T-151: Effect of Surface Dose and Depth of Maximum Dose with Physical Wedge Filters for 6MV Flattened and 7MV Unflattened Photon Beams.

PURPOSE: To evaluate impact on surface dose, Depth of dose maximum (dmax) and depth dose distribution due to physical wedge filters for different wedge angle were studied for 6MV flattened (6MV FB) and 7MV unflattened (7MV UFB) photon beams. METHODS: The flattening filter and primary collimator are the major sources of producing the scattered radiation and these parameters affect the surface dose, dmax and dose distribution. In this study, open fields surface dose, dmax and depth dose distribution values were compared with physical wedge filter for 6MV FB and 7MV UFB .The measurement carried out in Siemens - ARTISTE linear accelerator with diode detector along the central axis of the beam at 100 cm source to surface distance using IBA blue water phantom for 6MV FB and 7MV UFB x-ray beams. RESULTS: The surface dose increased as the field size increased for open and physical wedge fields for 6MV FB and 7MV UFB beams. For open fields, Surface doses relative to the dose at dmax ranged from 0.443 to 0.569 and 0.463 to 0.668 for field sizes of 5 × 5 to 20×20 cm2 for the 7MV UFB and 6MV FB beam respectively. The measured surface dose for 150, 300,450 and 600 wedge field values are 0.396 to 0.504, 0.366 to 0.484, 0.342 to 0.464 and 0.347 to 0.47 respectively for 7MV UFB and 0.424 to 0.566, 0.398 to 0.555, 0.3860 to 0.5430 and 0.389 to 0.55 respectively for 6MV FB. CONCLUSIONS: We found that dmax of wedged beams were higher than those open beams for field size up to 10 × 10 cm2 , Surface doses of wedged beams were lower than those of open beams for 7MV UFB and 6MV FB. Surface dose of the 7MV UFB were lower than the 6MV FB for open and wedged beams.

SU-E-T-149: Scatter Factors Comparison of 6MV Flattened and 7MV Unflattened Beams.

PURPOSE: To compare the Collimator scatter factor (Sc), Phantom scatter factor (Sp) and Total scatter factors (Sc,p) of 6MV flattened Beam (6MV FB) and 7MV Unflattened beams (7MV UFB). METHODS: The flattening filter and primary collimator are the major sources of producing the scattered radiation. In this study, the field sizes from 5×5 cm2 to 40 × 40 cm2 compared for 6MV FB and 7MV UFB. We measured Sc,p with CC 13 chamber at the depth of 10 g/cm2 using IBA blue phantom and Sc measured with CC 13 chamber at the depth of 10 g /cm2 using columnar phantom (TG 74) for 6MV FB and 7MV UFB x-ray beams from a Siemens - ARTISTE linear accelerator. The Sp values derived from the Sc,p and Sc Values. RESULTS: All the values of Sc,p, Sc and Sp are normalized to 10 × 10 cm2 field size the measured values of Sc,p for 6MV FB and 7MV UFB varies from 0.9437 to 1.0651 and 0.9690 to 1.0283 respectively. The Sc values for 6MV FB and 7MV UFB varies from 0.9676 to 1.0212 and 0.9882 to 1.0075 respectively. The Sp values for 6MV FB and 7MV UFB varies from 0.9752 to 1.0429 and 0.9806 to 1.0206 respectively. Our study results shows that Sc, Sp & Sc,p for 7MV UFB for smaller fields up to 10 × 10 cm2 were higher than 6MV FB and for larger fields greater than 10 ×10 cm2 it is vice versa. CONCLUSIONS: A scatter factors are measured and compared for 6MV FB and 7MV UFB. A significant variation observed for Sc, Sp and Sc,p values of 6MV FB and 7MV UFB .This is may be due to flattening filter and beam quality.

Accelerated partial breast irradiation using external beam radiotherapy-A feasibility study based on dosimetric analysis.

AIM: To investigate the feasibility of using External Beam radiotherapy for accelerated partial breast irradiation by a comparative tumour and normal tissue dose volume analysis with that of high dose rate interstitial brachytherapy. BACKGROUND: Accelerated Partial Breast Irradiation (APBI) is more clinically appealing because of the reduced treatment course duration and the irradiated area. Brachytherapy application is more dependent on the clinician's expertise when it is practised free hand without image guidance and a template. It happens to be an invasive procedure with the use of local anaesthesia which adds patient discomfort apart from its cost compared to External Beam Radiotherapy. But APBI with brachytherapy is more commonly practised procedure compared to EBRT owing to its previous reults. Hence in this research study, we intend to explore the use of EBRT with the radiobiological corrections for APBI in the place of brachytherapy. It is done as a dosimetric comparison of Brachytherapy treatment plans with that of EBRT plans. MATERIALS AND METHODS: The computed tomography images of 15 patients undergoing ISBT planning were simulated with conformal photon fields. Various dose volume parameters of each structure were obtained from the DVH generated in the brachytherapy and the simulated external beam planning which can correlate well with the late toxicity. The plan quality indices such as conformity index and homogeneity index for the target volume were computed from the dosimetric factors. The statistical p values for CI, HI and normal tissue dosimetric parameters were calculated and the confidence levels achievable were analysed. The dose prescribed in brachytherapy was 3400cGy in ten fractions. The equivalent prescription dose for the external beam radiotherapy planning was 3000cGy in five fractions applied with radiobiological correction. RESULTS: All the fifteen patients were with complete lung data and six were with left sided tumours having complete cardiac data. The lung dosimetry data and the cardiac dosimetry data of the patients were studied. Lower percentages of lung and cardiac V 20 and V 5 volumes were obtained with conformal planning. The conformity of radiation dose to the tumour volume was akin to the interstitial brachytherapy planning. Moreover the external beam planning resulted in more homogenous dose distribution. For the sampled population, the statistical analysis showed a confidence level of 95% for using EBRT as an alternate to multi catheter ISBT. CONCLUSION: The EBRT planning for Accelerated Partial Breast Irradiation was found to be technically feasible in the institution where the interstitial brachytherapy happens to be the only available technique as evident from the dose volume parameters and the statistical analysis.